- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Virbac SA (VIRB)
Assess today's live Virbac SA (VIRB) share price, performance and insights using our live Paris: VIRB stock exchange data.
Analyse the historical data and Virbac SA share price performance charts on this page. Our technical summary section provides analysis on Virbac share price buy/sell indicators using real-time data (or discuss the Virbac (VIRB) stock price today with other investors in the Virbac EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA VIRB share price (ISIN: FR0000031577) to enhance your trading decisions with our free investment tools and resources.
What Is the Virbac SA Share Price Today?
The Virbac share price today is 364.50.
What Is the Stock Symbol for Virbac SA
The stock symbol (or 'ticker') for Virbac SA is "VIRB."
What Stock Exchange Does Virbac SA Trade On?
Virbac SA is listed and trades on the Paris stock exchange.
Is Virbac SA a Good Stock to Buy?
Determining whether Virbac SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Virbac SA share price performance charts on this page. Our technical summary section provides analysis on Virbac share price buy/sell indicators using real-time data (or discuss the Virbac (VIRB) stock price today with other investors in the Virbac EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA VIRB share price (ISIN: FR0000031577) to enhance your trading decisions with our free investment tools and resources.
What Is the Virbac SA Share Price Today?
The Virbac share price today is 364.50.
What Is the Stock Symbol for Virbac SA
The stock symbol (or 'ticker') for Virbac SA is "VIRB."
What Stock Exchange Does Virbac SA Trade On?
Virbac SA is listed and trades on the Paris stock exchange.
Is Virbac SA a Good Stock to Buy?
Determining whether Virbac SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Currency in EUR
364.50
-5.50(-1.49%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
362.50
372.00
52 wk Range
296.00
389.50
VIRB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
362.50372.00
52 wk Range
296.00389.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.39%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.39%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VIRB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
413.00
Upside
+13.31%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
7 Buy
2 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 413.00
(+13.31% Upside)
Earnings
Latest Release
16/04/2026
EPS / Forecast
-- / --
Revenue / Forecast
384M / --
Compare VIRB to Peers and Sector
Metrics to compare | VIRB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVIRBPeersSector | |
|---|---|---|---|---|
P/E Ratio | 20.6x | 20.7x | −0.5x | |
PEG Ratio | 5.42 | 0.47 | 0.00 | |
Price/Book | 2.8x | 2.5x | 2.6x | |
Price / LTM Sales | 2.1x | 3.5x | 3.2x | |
Upside (Analyst Target) | 11.7% | 18.1% | 47.8% | |
Fair Value Upside | Unlock | 7.7% | 5.9% | Unlock |
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific. The company offers Vikaly, a cat food designed for the management of feline chronic kidney disease; Prevexto that contains imidacloprid and flumethrin, providing long-lasting parasite protection for dogs and cats at risk of fleas, ticks, lice, and sandflies; Zenidog/Zenifel offers a fogger, spray, and non-electric pheromone gel diffuser to soothe and reduce stress-related behaviors in dogs; Suigen Entero 3 is an inactivated vaccine aimed at preventing neonatal diarrhea in piglets caused by colibacillosis, clostridium, and rotavirus; Ursolyx that support muscle strength and mobility in dogs and cats; Zenifel a fogger and spray designed to reduce behaviors due to stress or undesirable behaviors in cats; Suigen PCV2 is a vaccine for porcine circovirus type 2; and Suigen Donoban is a multivalent vaccine used for the prevention of respiratory diseases in swine. It also provides a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. The company serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Virbac (Paris: VIRB) Share Price Today?
The Virbac stock price today is 364.50 EUR.
What Stock Exchange Does Virbac (VIRB) Trade On?
Virbac is listed and trades on the Paris Stock Exchange.
What Is the Ticker (Stock Symbol) for Virbac?
The stock symbol (also called a 'ticker') for Virbac is "VIRB."
Does Virbac Pay Dividends? What’s The Current VIRB Dividend Yield?
Yes, VIRB Pays Dividends to its Shareholders. The current Virbac dividend yield is 0.39%.
What Is the Current Virbac Market Capitalisation?
As of today, Virbac (Paris: VIRB) market cap is 3.05B EUR.
What Is Virbac's (VIRB) Earnings Per Share (TTM)?
The Virbac EPS is currently 18.00 (Trailing Twelve Months).
When Is the Next Virbac Earnings Date?
Virbac's next earnings report will be released on 16/04/2026.
Is VIRB a Buy or Sell From a Technical Analyst Perspective?
Based on today's Virbac moving averages and other technical indicators, the daily buy/sell signal for VIRB stock is Sell.
How Many Times Has Virbac Stock Split?
Virbac has split 2 times. (See the VIRB stock split history page for full effective split date and price information.)
How Many Employees Does Virbac Have?
Virbac has 6442 employees, based on their latest Companies House report.
What is the current trading status of Virbac (Paris: VIRB)?
As of 09/05/2026, Virbac (VIRB) is trading at a share price of 364.50 EUR, with a previous close of 370.00 EUR. The stock has fluctuated within a day range of 362.50 EUR to 372.00 EUR, while its 52-week range spans from 296.00 EUR to 389.50 EUR.
What Is Virbac (VIRB) Price Target According to Analysts?
The average 12-month price target for Virbac is 413.00 EUR, with a high estimate of 440 EUR and a low estimate of 368 EUR. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +13.31% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.